Janus Kinase Inhibitors and Body Weight: Current Evidence and Potential. [PDF]
Kraev K +9 more
europepmc +1 more source
A meta-analysis of the efficacy and safety of Janus kinase inhibitors in patients with ulcerative colitis. [PDF]
Yang Q, Yan Y.
europepmc +1 more source
Therapeutic Outcomes of Janus Kinase Inhibitors in Refractory Nail Lichen Planus: A Systematic Review. [PDF]
Aqeel S +9 more
europepmc +1 more source
Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors. [PDF]
Ippoliti E +5 more
europepmc +1 more source
Resolution of Hashimoto thyroiditis with Janus kinase inhibitor therapy in a patient with alopecia universalis. [PDF]
Trost SU, Radulescu A.
europepmc +1 more source
Public Interest in Janus Kinase (JAK) Inhibitors for Alopecia Areata: A Google Trend Analysis. [PDF]
Howard J +3 more
europepmc +1 more source
Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report. [PDF]
Wang L, Lei X, Li L, Cheng Q.
europepmc +1 more source
Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]
Malakar S, Giri S, Jena A, Nath P.
europepmc +1 more source
Diversifying the triquinazine scaffold of a Janus kinase inhibitor. [PDF]
Mulliri K +5 more
europepmc +1 more source
Janus kinase inhibitors in giant cell arteritis: unmet needs and new challenges. [PDF]
Gkouvi A +3 more
europepmc +1 more source

